Complementary cohort data further suggest that GLP-1 receptor agonists may slow knee osteoarthritis progression through combined mechanical load reduction and metabolic or anti-inflammatory pathways, as demonstrated in the Shanghai Osteoarthritis Cohort [57]. This evidence concerns the gene GLP1R and osteoarthritis.